509 related articles for article (PubMed ID: 10086663)
1. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer.
Tachibana M; Tabara H; Kotoh T; Kinugasa S; Dhar DK; Hishikawa Y; Masunaga R; Kubota H; Nagasue N
Am J Gastroenterol; 1999 Mar; 94(3):757-65. PubMed ID: 10086663
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment for locally advanced (T4) squamous cell carcinoma of the thoracic esophagus.
Tachibana M; Dhar DK; Kinugasa S; Yoshimura H; Shibakita M; Ohno S; Ueda S; Fujii T; Kohno H; Nagasue N
Dysphagia; 2002; 17(4):255-61. PubMed ID: 12355140
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus.
Tachibana M; Kinugasa S; Dhar DK; Kotoh T; Shibakita M; Ohno S; Masunaga R; Kubota H; Kohno H; Nagasue N
J Surg Oncol; 1999 Oct; 72(2):88-93. PubMed ID: 10518105
[TBL] [Abstract][Full Text] [Related]
7. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
[TBL] [Abstract][Full Text] [Related]
8. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
9. Factors predictive of prognosis after esophagectomy for squamous cell cancer.
Li H; Zhang Q; Xu L; Chen Y; Wei Y; Zhou G
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):55-9. PubMed ID: 19154903
[TBL] [Abstract][Full Text] [Related]
10. Surgical outcome of patients with thoracic esophageal cancer positive for cervical lymph nodes.
Shimada H; Shiratori T; Okazumi S; Matsubara H; Nabeya Y; Shuto K; Shimizu T; Hayashi H; Ochiai T
Hepatogastroenterology; 2007; 54(73):100-3. PubMed ID: 17419240
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors of curatively resected esophageal carcinoma associated with multiple metastatic lymph nodes.
Tabira Y; Sakaguchi T; Yoshida Y; Kuhara H; Kawasuji M
Hepatogastroenterology; 2006; 53(71):715-9. PubMed ID: 17086875
[TBL] [Abstract][Full Text] [Related]
12. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.
Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K
J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776
[TBL] [Abstract][Full Text] [Related]
13. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy].
Zhang DK; Su XD; Lin P
Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of lymph node metastases of 217 cases of thoracic esophageal carcinoma and its impact on prognosis].
An FS; Huang JQ; Chen SH
Ai Zheng; 2003 Sep; 22(9):974-7. PubMed ID: 12969532
[TBL] [Abstract][Full Text] [Related]
15. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
16. An audit of surgical outcomes of esophageal squamous cell carcinoma.
Goan YG; Chang HC; Hsu HK; Chou YP
Eur J Cardiothorac Surg; 2007 Mar; 31(3):536-44. PubMed ID: 17222561
[TBL] [Abstract][Full Text] [Related]
17. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
18. Pathologic prognostic factors in esophageal squamous cell carcinoma: a follow-up study of 74 patients with or without preoperative chemoradiation therapy.
Torres CM; Wang HH; Turner JR; Richards W; Sugarbaker D; Shahsafaei A; Odze RD
Mod Pathol; 1999 Oct; 12(10):961-8. PubMed ID: 10530561
[TBL] [Abstract][Full Text] [Related]
19. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].
Wang Z; Liu XY; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790
[TBL] [Abstract][Full Text] [Related]
20. [Surgical treatment and prognosis in patients with squamous cell carcinoma of thoracic esophagus].
Zhang DK; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Ma GW; Zhu ZH; Dai Y; Rong TH
Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(17):1333-6. PubMed ID: 19094566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
